Christopher Melton - 11 Dec 2025 Form 4 Insider Report for Caring Brands, Inc. (CBRA)

Reporting relationship: Director
Issuer ticker: CBRA
Reported as of: 11 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Dec 2025, 20:57:27 UTC
Prior SEC filing: 14 Nov 2025
Next SEC filing: 29 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Christopher Melton

Key filing fact

Christopher Melton filed Form 4 for Caring Brands, Inc. (CBRA) on 15 Dec 2025.

Key facts

This page summarizes Christopher Melton's Form 4 filing for Caring Brands, Inc. (CBRA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Dec 2025, 20:57.

Change

Previous filing in this sequence was filed on 14 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001533552 Primary reporting owner

Melton Christopher

Relationship: Director
Address: C/O CARING BRANDS, INC. 130 S INDIAN, RIVER DRIVE, SUITE 202 PBM# 1232, FORT PIERCE
Signature: /s/ Christopher Melton
Signature date: 15 Dec 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CABR transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +25,000
Change %
Price: $0.000000
Shares after: 25,000
Date: 11 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,000
Exercise price: $1.13
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On December 11, 2025, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan.

Footnote F2

The options vested immediately on December 11, 2025.